Taken together, functional characterization of the periostin/NAP1L2/SIRT3 axis dysregulation and subsequent BCAA catabolism impairment would provide mechanistic insights into the role of periostin in DCM progression. This evidence concerns the gene NAP1L2 and familial dilated cardiomyopathy.